Estimating Incidence of Respiratory Syncytial Virus- and Influenza Virus-Associated Hospitalizations with Community-Acquired Pneumonia and Other Acute Respiratory Infection Among Adults in Japan During and After the COVID-19 Era: A Multicenter Active Surveillance Study (APSG-J2)

BackgroundQuantifying the burden of respiratory syncytial virus (RSV) in adults is challenging compared to influenza, and data among older adults remain scarce in Japan. Country-specific evidence is essential to support RSV vaccination policy. MethodsThis prospective, multicenter study (APSG-J2) targeted hospitalized adults with community-acquired pneumonia (CAP) and other acute respiratory infection (ARI) in seven community-hospitals across four catchment areas in Japan between September 2022 and August 2024. Respiratory samples were analyzed using a multiplex polymerase chain reaction (PCR) kit to detect RSV and influenza. Incidence rates of RSV- and influenza-associated hospitalizations were estimated using study data and national statistics, stratified by age and region. ResultsAmong 3,047 hospitalized patients with CAP/ARI, 1,502 (49.3%) underwent multiplex PCR testing. RSV and influenza were detected in 2.8% and 3.3% of tested patients, respectively. The incidences of RSV-associated CAP/ARI hospitalizations among adults aged [≥]65 years were 29 and 36 per 100,000 person-years in the first and second years, respectively, with higher incidences among those aged [≥]85 years (150 and 131 per 100,000 person-years). Influenza incidence increased markedly in the second year (from 11 to 71 per 100,000 person-years for adults age [≥]65 years), possibly reflecting post-COVID-19 transmission changes. ConclusionsThis is the first active surveillance study in Japan to estimate RSV- and influenza-associated hospitalization incidence among adults during and after the COVID-19 era. The results may still be influenced by the lingering effects of COVID-19 restrictions on social interaction. Continued surveillance is essential to accurately assess RSV burden in the adult population.